Peptides · Peptide comparison
CJC-1295 with DAC vs Sermorelin
Long-acting growth hormone releaser that works around the clock to boost your body's natural GH production with just one or two injections per week.
The original growth hormone booster that works with your body's natural rhythm—it tells your pituitary gland to release more GH instead of replacing it, keeping your hormonal feedback system healthy and balanced.
- Growth Hormone
- Growth Hormone
At a glance
Quick comparison
Efficacy
Benefit ratings
GH Elevation
Convenience
Recovery Support
GH Optimization
Sleep Quality
Body Composition
Technical data
Compound specifications
CJC-1295 with DAC
- Molecular formula
- C165H269N47O46
- Molecular weight
- 3647.28 g/mol
- Half-life
- 6-8 days
- Bioavailability
- ~100% (subcutaneous)
- CAS number
- 863288-34-0
Sermorelin
- Molecular formula
- C149H246N44O42S
- Molecular weight
- 3357.9 g/mol
- Half-life
- 10-20 minutes
- Bioavailability
- High when injected subcutaneously; degraded orally
- CAS number
- 86168-78-7
Protocols
Dosing compared
CJC-1295 with DAC
Subcutaneous
- 1 mg (1000 mcg)Once weekly · 2-4 weeksA starting dose used in practice. The DAC version is long-acting (about a 6-8 day half-life), so weekly dosing keeps growth hormone and IGF-1 raised. In the Phase 1 trial a single dose raised GH for 6+ days and IGF-1 for up to 11 days. [2]
- 2 mg (2000 mcg)Once weekly (or split twice weekly) · 8-12 weeksThe common maintenance dose, roughly in line with the 30-60 mcg/kg weekly range studied in the Phase 1 trial. [1][2] In the ascending-dose trials, single injections raised mean GH 2- to 10-fold for six or more days and IGF-I 1.5- to 3-fold for 9-11 days; 30 and 60 µg/kg doses were the best tolerated [2].
- 2 mg per doseTwice weekly · 8-12 weeksA higher total weekly amount split into two doses, used by experienced users; near the top of the 30-60 mcg/kg weekly range from the clinical study. [2]
Sermorelin
Subcutaneous
- 100-200 mcgOnce daily at bedtime · 4-6 weeksCommunity-practice dose, not one studied in adults. The adult trials used 0.5–1 mg twice daily [1] or 2 mg nightly [3]; the pediatric label dose was 30 mcg/kg at bedtime [6].
- 200-300 mcgOnce daily at bedtime · 3-6 monthsCommunity-practice dose. Twice-daily 1 mg (not 200–300 mcg) is the dose that restored GH and IGF-1 in older men [1].
Applications
Best suited for
CJC-1295 with DAC
- Growth Hormone Optimization
- CJC-1295 with DAC excels at providing a sustained, steady elevation of growth hormone levels. Unlike shorter-acting peptides that create brief spikes, the DAC modification keeps GH elevated for days, mimicking a more youthful hormone profile.
- Muscle Building and Recovery
- By increasing both GH and IGF-1 levels, this peptide supports protein synthesis and muscle repair. Users often notice improved recovery between workouts and better ability to build and maintain lean muscle mass.
- Anti-Aging and Longevity
- Growth hormone naturally declines with age, contributing to many signs of aging. CJC-1295 with DAC helps restore more youthful GH levels, potentially supporting better skin quality, energy levels, and overall vitality.
- Body Composition Improvement
- The combination of increased GH and IGF-1 promotes fat metabolism while preserving muscle tissue. Many users experience gradual fat loss, particularly in stubborn areas, while maintaining or building lean mass.
- Convenient Weekly Dosing
- Unlike peptides requiring daily or twice-daily injections, the extended half-life of CJC-1295 with DAC means just one or two injections per week provide continuous benefits. Ideal for those who want results without daily protocols.
Sermorelin
- Adults Experiencing Age-Related GH Decline
- After age 30, your growth hormone production naturally declines about 14% per decade. [9] Sermorelin helps restore more youthful GH levels by stimulating your own pituitary rather than shutting it down with external hormones. [1][13] It's like giving your hormone system a gentle nudge back to where it used to be.
- Body Composition Optimizers
- Evidence for body composition is limited. A GHRH analog increased lean mass in older men but not women, with no change in fat [2]; 6 weeks of nightly sermorelin changed neither muscle nor fat [3]. Larger, longer studies are lacking. [8]
- Sleep Quality Seekers
- Growth hormone is intimately tied to deep, restorative sleep. [10] By enhancing your natural nighttime GH pulses, sermorelin often improves sleep quality as a welcome side effect. [8] Many users report falling asleep faster and waking more refreshed.
- Those Wanting a Safer Alternative to HGH
- Direct HGH injections bypass your body's feedback system and can suppress your own production. [13] Sermorelin works differently—it asks your pituitary to make more GH naturally. This preserves your body's regulatory mechanisms and carries a lower risk of side effects. [8]
Safety profile
Side effects
CJC-1295 with DAC
Common
- Injection site reactions
- Water retention
- Flushing
- Tingling sensation
Uncommon
- Headaches
- Fatigue or lethargy
- Joint discomfort
Serious
- Carpal tunnel symptoms
- Blood glucose elevation
Sermorelin
Common
- Injection site reactions
- Facial flushing
Uncommon
- Headache
- Sleepiness or drowsiness
- Nausea
- Hyperactivity or difficulty sleeping
Serious
- Severe allergic reaction
Research status
Safety & evidence
CJC-1295 with DAC
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Research compound
- Safety overview
- CJC-1295 with DAC was evaluated in Phase 1-2 human clinical trials where it demonstrated a generally favorable safety profile. The most common adverse events were mild injection site reactions including temporary pain, swelling, and redness. No serious adverse events were reported in the published clinical studies. The compound was being developed for HIV-associated lipodystrophy before the program was discontinued.
Contraindications
- Active cancer or history of malignancy
- Pregnancy or breastfeeding
- Pituitary tumors or disorders
- Diabetic retinopathy
- Uncontrolled diabetes
Sermorelin
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Not currently FDA approved. GEREF (sermorelin) was approved in 1997 for growth failure in children with GH deficiency; EMD Serono discontinued it in 2008 and FDA withdrew the approvals at its request in 2009, not for safety or effectiveness reasons. Sermorelin sold today is compounded, not an FDA-approved product.
- Safety overview
- Sermorelin works through the body's own GH feedback, which limits excessive hormone levels. [8][13] On the GEREF label, the most common reaction to repeated injections was a local reaction (about 1 in 6 patients); headache, flushing, dizziness, hyperactivity and somnolence each occurred in under 1%, and many patients developed anti-GRF antibodies. [16] Facial flushing and injection-site pain were the most commonly reported events in the pediatric studies. [6] GEREF was FDA-approved in 1997 for children with GH deficiency. [7]
Contraindications
- Active cancer or history of cancer
- Pregnancy or breastfeeding
- Known allergy to sermorelin or any peptide components
- Pituitary tumors or other pituitary disorders
- Diabetic retinopathy
Decision guide
Which is right for you?
CJC-1295 with DAC
Choose CJC-1295 with DAC if…
- Boosting natural growth hormone production
- Building lean muscle mass
- Improving body composition
- Anti-aging and longevity
Sermorelin
Choose Sermorelin if…
- Anti-aging and vitality
- Body composition improvement
- Sleep quality enhancement
- Exercise recovery